Otsuka Holdings Co (JP:4578) has released an update.
Otsuka Pharmaceutical Factory America, a subsidiary of Otsuka Pharmaceutical Factory, has partnered with ICU Medical to form a joint venture in the North American IV solution market, with operations beginning in early Q2 2025. Otsuka will hold a 60% stake in the new company, aiming to strengthen the supply chain and drive innovation amid a temporary IV solution shortage in the U.S. This strategic move aligns with Otsuka’s global expansion goals and commitment to enhancing healthcare worldwide.
For further insights into JP:4578 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- M&A News: Paramount’s (NASDAQ:PARA) Merger with Skydance May Get Delayed
- Ford (NYSE:F) Cuts Hours At German EV Plant
- Did Intel (NASDAQ:INTC) Win the “Server Recession?”
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
